Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jul 27;12(7):e009232. doi: 10.1136/jitc-2024-009232

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Prognostic value of TLSs presence and density in BCBM patients and correlation between TLSs and different breast subtype. (A, B) Kaplan-Meier and log-rank tests identifying the predictive value of the presence of TLSs for OS and PFS. (C, D) Kaplan-Meier curves showing OS and PFS of BCBM patients stratified by TLS scores. (E, F) Kaplan-Meier curves for OS and PFS in the HER2+ subtype according to the presence of TLSs. (H, I). Kaplan-Meier curves for OS and PFS in the TNBC subtype according to the presence of TLSs. BCBM, breast cancer brain metastases; HER2, human epidermal growth factor receptor type 2; OS, overall survival; PFS, progression-free survival; TLS, tertiary lymphoid structure; TNBC, triple-negative breast cancer.